StockData
ELANNYSEPharmaceutical PreparationsFiscal year ends December 31

Elanco Animal Health Inc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$23.49−0.06 (-0.25%)

Close on Oct 19, 2026

Market cap
$11.88B
P/E (TTM)
–
Dividend yield
–

Elanco Animal Health statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison

Valuation

MeasureElanco Animal HealthIndustry median
Market Cap$11.74B$166.30M
Enterprise Value$15.12B$88.19M
PS Ratio2.343.65
PB Ratio1.782.03
P/FCF Ratio30.9717.44
P/OCF Ratio19.0212.98

Enterprise value

MeasureElanco Animal HealthIndustry median
EV / Sales3.012.51
EV / EBITDA28.7014.65
EV / FCF39.9120.86

Income (trailing twelve months)

MeasureElanco Animal HealthIndustry median
Revenue$5.02B$58.34M
Gross Profit$2.78B$105.94M
Pretax Income-$166.00M-$14.34M
Net Income-$199.00M-$22.46M
EBITDA$527.00M-$16.91M
EPS (Diluted)-$0.42-$0.83

Margins

MeasureElanco Animal HealthIndustry median
Gross Margin55.4%52.9%
Pretax Margin-3.31%-13.3%
Profit Margin-3.96%-40.2%
EBITDA Margin10.5%-30.2%
FCF Margin7.55%-9.27%

Returns

MeasureElanco Animal HealthIndustry median
Return on Equity (ROE)-2.98%-53.2%
Return on Assets (ROA)-1.46%-40.9%

Growth

MeasureElanco Animal HealthIndustry median
Revenue Growth (YoY)12.0%5.96%
Net Income Growth (YoY)-145.9%-35.2%
EPS Growth (YoY)-148.8%-26.2%
FCF Growth (YoY)4.99%2.34%
Revenue Growth (3Y CAGR)2.25%2.25%
Revenue Growth (5Y CAGR)7.59%6.48%

Balance sheet

MeasureElanco Animal HealthIndustry median
Cash & Short-Term Investments$530.00M$61.43M
Total Debt$3.92B$118.52M
Net Cash (Debt)-$3.39B$15.35M
Net Cash Per Share-$6.78$0.66
Equity (Book Value)$6.59B$49.09M
Book Value Per Share$13.19$1.37
Tangible Book Value-$1.46B$23.52M
Working Capital$1.95B$76.81M

Financial position

MeasureElanco Animal HealthIndustry median
Current Ratio2.053.34
Quick Ratio0.872.44
Debt / Equity0.590.52
Debt / EBITDA7.433.44
Debt / FCF10.344.89
Net Debt / EBITDA6.432.36

Cash flow (trailing twelve months)

MeasureElanco Animal HealthIndustry median
Operating Cash Flow$617.00M-$12.35M
Capital Expenditures-$238.00M-$1.08M
Free Cash Flow$379.00M-$20.22M
FCF Per Share$0.76-$0.42

Efficiency

MeasureElanco Animal HealthIndustry median
Asset Turnover0.370.39
Inventory Turnover1.302.70
Revenue Per Employee$534.04K$404.87K
Profits Per Employee-$21.17K-$703.34K
Employee Count9,40074

Dividends and yields

MeasureElanco Animal HealthIndustry median
Earnings Yield-1.70%-23.3%
FCF Yield3.23%-8.72%

Shares

MeasureElanco Animal HealthIndustry median
Shares Outstanding499,622,00058,127,000
Shares Change (YoY)-0.24%10.9%
Shares Change (QoQ)0.03%0.54%
Float494,301,00049,136,700
Shares Held by Insiders1.07%11.6%
Shares Held by Institutions113.5%59.4%

Taxes

MeasureElanco Animal HealthIndustry median
Income Tax$33.00M$79.87K

Scores

MeasureElanco Animal HealthIndustry median
Altman Z-Score1.34-0.22
Piotroski F-Score64
Beneish M-Score-2.66-2.62

Calculated by StockData from Elanco Animal Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.